<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Cardiovasc Disord</journal-id><journal-id journal-id-type="iso-abbrev">BMC Cardiovasc Disord</journal-id><journal-title-group><journal-title>BMC Cardiovascular Disorders</journal-title></journal-title-group><issn pub-type="epub">1471-2261</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31924163</article-id><article-id pub-id-type="pmc">6954587</article-id><article-id pub-id-type="publisher-id">1315</article-id><article-id pub-id-type="doi">10.1186/s12872-019-01315-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>The Prognostic Significance of Different Bleeding Classifications in off-pump coronary artery bypass grafting</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Xi</surname><given-names>Ziwei</given-names></name><address><email>xixixiziwei@qq.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Yanan</given-names></name><address><email>gaoyanan9412@126.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Zhenxian</given-names></name><address><email>zxy319sh@sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhou</surname><given-names>Yu-Jie</given-names></name><address><email>azzyj12@163.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0060-1274</contrib-id><name><surname>Liu</surname><given-names>Wei</given-names></name><address><email>liuwei@ccmu.edu.cn</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>Department of Cardiology, </institution><institution>Beijing Anzhen hospital, Capital Medical University, </institution></institution-wrap>Anzhen Road, Chaoyang District, Beijing, 100029 China </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>1</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>20</volume><elocation-id>3</elocation-id><history><date date-type="received"><day>12</day><month>7</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>12</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Perioperative bleeding during cardiac surgery are known to make patients susceptible to adverse outcomes and several bleeding classifications have been developed to stratify the severity of bleeding events. Further validation of different classifications was needed. The aim of present study was to validate and explore the prognostic value of different bleeding classifications in patients undergoing off-pump coronary artery bypass grafting (OPCAB).</p></sec><sec><title>Methods</title><p id="Par2">Data on baseline and operative characteristics of 3988 patients who underwent OPCAB in Beijing Anzhen Hospital from February 2008 to December 2014 were available. The primary endpoint was a composite of in-hospital death and nonfatal postoperative myocardial infarction (MI). The secondary endpoint was postoperative acute kidney injury (AKI). We explored the association of major bleeding defined by the European registry of Coronary Artery Bypass Grafting (E-CABG), Universal Definition of Perioperative Bleeding (UDPB), Bleeding Academic Research Consortium (BARC) classification and Study of Platelet Inhibition and Patient Outcomes (PLATO) with primary endpoints by multivariable logistic regression analysis and investigated their significance of adverse event prediction using goodness-of-fit tests of &#x02212;&#x02009;2 log likelihood.</p></sec><sec><title>Results</title><p id="Par3">In-hospital mortality was 1.23% (<italic>n</italic>&#x02009;=&#x02009;49) and postoperative MI was observed in 4.76% (<italic>n</italic>&#x02009;=&#x02009;190) of patients, AKI in 24.69% (<italic>n</italic>&#x02009;=&#x02009;985). The incidence of the primary outcome was 5.99% (<italic>n</italic>&#x02009;=&#x02009;239). Multivariable logistic regression analysis showed that BARC type 4 (OR&#x02009;=&#x02009;2.64, 95% CI: 1.66&#x02013;4.19, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001), UDPB class 4 (OR&#x02009;=&#x02009;3.52, 95% CI: 2.05&#x02013;6.02, P&#x02009;&#x0003c;&#x02009;0.001) and E-CABG class 2&#x02013;3 (class 2: OR&#x02009;=&#x02009;2.24, 95% CI: 1.36&#x02013;3.70, <italic>P</italic>&#x02009;=&#x02009;0.001; class 3: OR&#x02009;=&#x02009;12.65, 95% CI: 2.74&#x02013;18.43, <italic>P</italic>&#x02009;=&#x02009;0.002) bleeding but not PLATO bleeding were associated with an increased risk of in-hospital death and postoperative MI. Major bleeding defined by all the four classifications mentioned above was an independent risk factor of AKI after surgery. Inclusion of major bleeding defined by these four classifications improved the predictive performance of the multivariable model with baseline characteristics.</p></sec><sec><title>Conclusions</title><p id="Par4">Bleeding assessed by BARC, E-CABG and UDPB classifications were significantly associated with poorer immediate outcomes. These classifications seemed to be valuable tool in the assessment of prognostic effect of perioperative bleeding.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Bleeding</kwd><kwd>Off-pump coronary artery bypass grafting (OPCAB)</kwd><kwd>European registry of coronary artery bypass grafting (E-CABG)</kwd><kwd>Universal definition of perioperative bleeding (UDPB)</kwd><kwd>Bleeding academic research consortium (BARC)</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par14">Perioperative bleeding is a common concern in patients undergoing cardiac surgery [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Bleeding complications have been proven to be associated with an increased risk of subsequent adverse outcomes including infection [<xref ref-type="bibr" rid="CR3">3</xref>], myocardial infarction, stroke, stent thrombosis, and death [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par15">A variety of definitions of bleeding were proposed to stratify the severity of bleeding which was as an important endpoint to assess the efficacy and safety of procedure [<xref ref-type="bibr" rid="CR7">7</xref>]. However, different definitions are used across clinical trials and registries, hampering direct comparison across studies [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Moreover, few definitions were specifically developed for bleeding occurring after CABG [<xref ref-type="bibr" rid="CR10">10</xref>]. The clinical significance of most definitions has been evaluated and validated to date only by their proposers [<xref ref-type="bibr" rid="CR11">11</xref>]. The aim of the present study was to validate and compare the prognostic value of different bleeding definitions in patients undergoing off-pump coronary artery bypass grafting (OPCAB).</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Patient population and data collection</title><p id="Par16">Our retrospective, single-center, cohort study enrolled a total of 3988 consecutive patients aged &#x0003e;&#x02009;18&#x02009;years who had undergone isolated OPCAB between February 2008 to December 2014 in Beijing Anzhen Hospital (Beijing, China), including emergency and elective operations performed in off-pump setting. The major exclusion criteria were: 1) preoperative exposure to oral anticoagulants including warfarin and direct oral anticoagulants, 2) preoperative severe renal insufficient, 3) undergoing any other major cardiac surgery procedure including valvular repair or replacement, 4) and with insufficient records to specify bleeding events. The detailed study flowchart is depicted in Fig. <xref rid="Fig1" ref-type="fig">1</xref>. All patients provided written informed consent for the procedure and subsequent clinical data for retrospective analysis on the day of admission. The ethical review and informed consent of this study were approved by institutional ethics committee of Beijing Anzhen Hospital, Capital Medical University. The protocols of our study obeyed the principles of the 1983 Declaration of Helsinki.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Study flowchart</p></caption><graphic xlink:href="12872_2019_1315_Fig1_HTML" id="MO1"/></fig></p><p id="Par17">All data used int the present study was collected from the electronic medical records by two trained medical staffs. The important data information was monitored and revised by a third medical staff to ensure the accuracy. The database of the electronic medical system contained the baseline and operative data and immediate postoperative adverse events, which provided available complete pre-, intra-, and postoperative data for all included patients.</p></sec><sec id="Sec4"><title>Endpoints and definitions</title><p id="Par18">The primary endpoint of this study was a composite of in-hospital death and postoperative myocardial infarction (MI). In-hospital death included all-cause death before discharge and post operation. The postoperative MI was defined as nonfatal elevation of cardiac troponin (cTn) values &#x0003e;&#x02009;10 times the 99th percentile upper reference limit (URL) in patients with normal baseline cTn values [<xref ref-type="bibr" rid="CR12">12</xref>]. The secondary endpoint was postoperative acute kidney injury (AKI) which was defined as an acute postoperative renal insufficiency resulting in one or more of the following in the first 48&#x02009;h after surgery as proposed by Acute Kidney Injury Network (AKIN) as stage 1 of acute kidney injury: 1) an increase of serum creatinine level of &#x02265;0.3&#x02009;mg/dl (&#x02265; 26.4&#x02009;&#x003bc;mol/l); 2) at least a 50% greater increase in creatinine above baseline preoperative level (1.5-fold from baseline); 3) a reduction in urine output (documented oliguria of less than 0.5&#x02009;ml/kg per hour for more than six hours) [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par19">Major bleeding events were assessed and adjudicated according to the classification from European registry of Coronary Artery Bypass Grafting (E-CABG), [<xref ref-type="bibr" rid="CR8">8</xref>] the Universal Definition of Perioperative Bleeding (UDPB), [<xref ref-type="bibr" rid="CR9">9</xref>] the Bleeding Academic Research Consortium (BARC) [<xref ref-type="bibr" rid="CR14">14</xref>] classification and the classification from Study of Platelet Inhibition and Patient Outcomes (PLATO) [<xref ref-type="bibr" rid="CR15">15</xref>].</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par20">Baseline continuous variables were presented as mean value &#x000b1; standard deviation if normally distributed and otherwise as median (interquartile range). Categorical variables are expressed as percentages.</p><p id="Par21">Multivariable logistic regression analysis was used to investigate the association between perioperative major bleeding and endpoints adjusting for potential confounding factors which had been reported in previous studies, using forward stepwise selection to identify significant confounding variables. Potential confounders reported in previous studies as important determinants of perioperative outcomes and variables suggested to be associated with clinical outcomes by univariate logistic analysis would be offered to the logistic regression models. Power of the association between risk factors and outcomes was expressed as odds ratio (OR) and 95% confidence intervals (CI). Goodness-of-fit tests of &#x02212;&#x02009;2 log likelihood were used to evaluate the improved model performance comparing models with and without bleeding.</p><p id="Par22">Statistical analysis was performed with the SPSS version 24.0 statistical software (IBM Corporation, Armonk, New York, USA). All statistical tests were 2-sided and results were considered to be statistically significant at a <italic>p</italic> value &#x0003c;&#x02009;0.05.</p></sec></sec><sec id="Sec6"><title>Results</title><p id="Par23">Baseline demographic characteristics of the overall 3988 patients included in the present study were reported in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Baseline Characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Variable</th><th>No. (%) / Mean&#x02009;+&#x02009;SD</th></tr></thead><tbody><tr><td>Age (years)</td><td>62.15&#x02009;&#x000b1;&#x02009;9.10</td></tr><tr><td>Female gender</td><td>947 (23.75%)</td></tr><tr><td>BMI (kg/m2)</td><td>25.72&#x02009;&#x000b1;&#x02009;3.18</td></tr><tr><td>SBP (mmHg)</td><td>129.07&#x02009;&#x000b1;&#x02009;19.19</td></tr><tr><td>LVEF (%)</td><td>56.11&#x02009;&#x000b1;&#x02009;10.04</td></tr><tr><td>LVEF&#x0003c;&#x02009;40%</td><td>119 (2.98%)</td></tr><tr><td>Hemoglobin (g/L)</td><td>139.25&#x02009;&#x000b1;&#x02009;16.23</td></tr><tr><td>BMI&#x02009;&#x02264;&#x02009;25</td><td>1764 (44.23%)</td></tr><tr><td>Hypertension</td><td>2600 (65.20%)</td></tr><tr><td>Diabetes</td><td>1411 (35.38%)</td></tr><tr><td>Hyperlipidemia</td><td>922 (23.12%)</td></tr><tr><td>Prior MI</td><td>566 (14.19%)</td></tr></tbody></table></table-wrap></p><sec id="Sec7"><title>Bleeding events and clinical outcomes</title><p id="Par24">In the 3988 OPCAB patients analyzed, in-hospital mortality was 1.23% (<italic>n</italic>&#x02009;=&#x02009;49) and postoperative MI occurred in 5.01% (<italic>n</italic>&#x02009;=&#x02009;200) of patients. And 24.70% (<italic>n</italic>&#x02009;=&#x02009;985) of patients suffered from AKI after procedure.</p><p id="Par25">BARC CABG-related bleeding (type 4) occurred in 168 (4.21%) patients. The incidence of major bleeding defined by E-CABG class 2&#x02013;3 and UDPB class 3&#x02013;4 were 4.16% (<italic>n</italic>&#x02009;=&#x02009;166) and 9.85% (<italic>n</italic>&#x02009;=&#x02009;393). And the incidence of major bleeding according to PLATO criteria was 36.28% (<italic>n</italic>&#x02009;=&#x02009;1447). All major bleeding events defined as E-CABG class 2&#x02013;3 were concomitantly captured in both BARC type 4 and UDPB class 3&#x02013;4 bleeding (98.8% in BARC type 4 and 42.2% in UDPB class 3&#x02013;4). The incidence rates of adverse outcomes including composite endpoints, in-hospital death, MI and AKI among patients with minor or major bleeding classified by different bleeding classifications were summarized in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>. Among patients with bleeding events, increasing grades of E-CABG and UDPB classifications but not PLATO were associated with increasing risk of in-hospital death (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001).
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Incidence of adverse events after procedure according to various bleeding classification</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Classifications/Outcomes</th><th colspan="5">Severity of perioperative bleeding</th></tr><tr><th>UDPB</th><th>0</th><th>1</th><th>2</th><th>3</th><th>4</th></tr></thead><tbody><tr><td>Composite outcomes [n (%)]</td><td>118 (6.37%)</td><td>21 (5.36%)</td><td>70 (5.18%)</td><td>24 (8.22%)</td><td>19 (18.81%)</td></tr><tr><td>In-hospital death [n (%)]</td><td>18 (0.97%)</td><td>2 (0.51%)</td><td>16 (1.18%)</td><td>4 (1.37%)</td><td>9 (8.91%)</td></tr><tr><td>MI [n (%)]</td><td>99 (5.35%)</td><td>17 (4.34%)</td><td>53 (3.92%)</td><td>18 (6.16%)</td><td>13 (12.87%)</td></tr><tr><td>AKI [n (%)]</td><td>375 (20.25%)</td><td>82 (20.92%)</td><td>400 (29.61%)</td><td>85 (29.11%)</td><td>43 (42.57%)</td></tr><tr><td>BARC</td><td>without Type 4</td><td colspan="4">Type 4: CABG-related bleeding</td></tr><tr><td>Composite outcomes [n (%)]</td><td>229 (5.99%)</td><td/><td/><td>23 (13.69%)</td><td/></tr><tr><td>In-hospital death [n (%)]</td><td>40 (1.05%)</td><td/><td/><td>9 (5.36%)</td><td/></tr><tr><td>MI [n (%)]</td><td>183 (4.79%)</td><td/><td/><td>17 (10.12%)</td><td/></tr><tr><td>AKI [n (%)]</td><td>919 (24.06%)</td><td/><td/><td>66 (39.29%)</td><td/></tr><tr><td>PLATO</td><td>minimal bleeding</td><td>minor bleeding</td><td>other major bleeding</td><td>major life-threatening bleeding</td><td/></tr><tr><td>Composite outcomes</td><td>35 (6.22%)</td><td>1 (5.88%)</td><td>89 (4.74%)</td><td>114 (7.45%)</td><td/></tr><tr><td>In-hospital death</td><td>4 (0.71%)</td><td>0</td><td>12 (0.64%)</td><td>33 (2.16%)</td><td/></tr><tr><td>MI</td><td>32 (5.68%)</td><td>1 (5.88%)</td><td>78 (4.15%)</td><td>89 (5.82%)</td><td/></tr><tr><td>AKI</td><td>121 (21.49%)</td><td>5 (29.41%)</td><td>422 (22.47%)</td><td>437 (28.56%)</td><td/></tr><tr><td>E-CABG</td><td>0</td><td>1</td><td>2</td><td>3</td><td/></tr><tr><td>Composite outcomes</td><td>147 (5.94%)</td><td>69 (5.13%)</td><td>20 (12.42%)</td><td>3 (42.85%)</td><td/></tr><tr><td>In-hospital death</td><td>23 (0.97%)</td><td>17 (1.26%)</td><td>6 (3.73%)</td><td>3 (42.85%)</td><td/></tr><tr><td>MI</td><td>128 (5.17%)</td><td>55 (4.09%)</td><td>12 (7.45%)</td><td>2 (28.57%)</td><td/></tr><tr><td>AKI</td><td>506 (20.44%)</td><td>413 (30.71%)</td><td>60 (3.79%)</td><td>6 (85.71%)</td><td/></tr></tbody></table></table-wrap></p></sec><sec id="Sec8"><title>Multivariable logistic model and comparison of classifications</title><p id="Par26">The results of the multivariable logistic models to evaluate the association between bleeding and adverse outcomes were shown in Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>. BARC type 4 bleeding which was specific for bleeding related to CABG was independently associated with a more than 2-fold increase in risk of in-hospital death and postoperative MI (OR&#x02009;=&#x02009;2.54, 95% CI: 1.66&#x02013;4.19, <italic>P</italic>&#x02009;&#x0003c;&#x02009;0.001). Major bleedings defined as E-CABG class 2 and 3 (class 2: OR&#x02009;=&#x02009;2.24, 95% CI: 1.36&#x02013;3.70, <italic>P</italic>&#x02009;=&#x02009;0.001; class 3: OR&#x02009;=&#x02009;12.65, 95% CI: 2.74&#x02013;18.43, <italic>P</italic>&#x02009;=&#x02009;0.002) or UDPB class 4 (OR&#x02009;=&#x02009;3.52, 95% CI: 2.05&#x02013;6.02, P&#x02009;&#x0003c;&#x02009;0.001) were significantly associated with poorer perioperative clinical outcomes.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Association of bleeding and primary endpoints according to multivariable models</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th rowspan="2">OR</th><th colspan="2">95% CI</th><th rowspan="2"><italic>p</italic>-value</th></tr><tr><th>Lower</th><th>Upper</th></tr></thead><tbody><tr><td>BARC type 4 bleeding</td><td>2.64</td><td>1.66</td><td>4.19</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td colspan="5">E-CABG</td></tr><tr><td>&#x02003;1</td><td>0.87</td><td>0.65</td><td>1.17</td><td>0.363</td></tr><tr><td>&#x02003;2</td><td>2.24</td><td>1.36</td><td>3.70</td><td>0.002</td></tr><tr><td>&#x02003;3</td><td>12.65</td><td>2.74</td><td>58.44</td><td>0.001</td></tr><tr><td colspan="5">UDPB</td></tr><tr><td>&#x02003;1</td><td>0.78</td><td>0.47</td><td>1.28</td><td>0.319</td></tr><tr><td>&#x02003;2</td><td>0.80</td><td>0.59</td><td>1.10</td><td>0.172</td></tr><tr><td>&#x02003;3</td><td>1.25</td><td>0.77</td><td>2.02</td><td>0.365</td></tr><tr><td>&#x02003;4</td><td>3.52</td><td>2.05</td><td>6.02</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td colspan="5">PLATO</td></tr><tr><td>&#x02003;Minor</td><td>0.89</td><td>0.11</td><td>6.97</td><td>0.910</td></tr><tr><td>&#x02003;Other major</td><td>0.75</td><td>0.49</td><td>1.13</td><td>0.162</td></tr><tr><td>&#x02003;Major life-threatening bleeding</td><td>1.19</td><td>0.79</td><td>1.80</td><td>0.398</td></tr></tbody></table></table-wrap></p><p id="Par27">We created a multivariable model using baseline characteristics such as age, gender, BMI, diabetes, hypertension, prior MI, renal insufficiency, decreased left ventricular ejection fraction (LVEF), systolic blood pressure (SBP) values and preoperative haematocrit (Hct) values and different bleeding classifications were added to this multivariable model to evaluate whether the inclusion of bleeding events could improve the predictive value of this model. The inclusion of bleeding stratified by BARC, E-CABG and UDPB improved the prediction of in-hospital death and postoperative MI (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). BARC type 4 bleeding and E-CABG class 2&#x02013;3 bleeding improved the model to similar degrees.
<table-wrap id="Tab4"><label>Table 4</label><caption><p>Improvement in predictive value of multivariable model</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Change in -2log likelihood vs. Baseline Model</th><th><italic>p</italic>-value</th></tr></thead><tbody><tr><td>Baseline + BARC type 4</td><td>1794.27&#x02013;1780.49&#x02009;=&#x02009;13.78</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Baseline + E-CABG class 2&#x02013;3</td><td>1794.27&#x02013;1780.50&#x02009;=&#x02009;13.77</td><td>&#x0003c;&#x02009;0.001</td></tr><tr><td>Baseline + PLATO major</td><td>1794.27&#x02013;1788.79&#x02009;=&#x02009;5.48</td><td>0.222</td></tr><tr><td>Baseline + UDPB class 3&#x02013;4</td><td>1794.27&#x02013;1781.79&#x02009;=&#x02009;12.48</td><td>&#x0003c;&#x02009;0.001</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="Sec9"><title>Discussion</title><p id="Par28">Our results indicated that BARC, E-CABG and UDPB but not PLATO classifications can effectively stratify the severity of postoperative bleeding. Moreover, bleedings classified as BARC type 4, E-CABG class 2 and 3 and UDPB class 4 were independently associated with an increased risk of in-hospital death and postoperative MI.</p><p id="Par29">Bleeding has been recognized as important determinants of outcomes after cardiac surgery according previous studies [<xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR18">18</xref>]. Quantifying the amounts of blood products transfusions is an important factor to measure the severity of bleeding. A study from Koch et al. demonstrated the correlation between RBC transfusion and increased risk of postoperative morbid events including mortality, renal failure, prolonged ventilatory support, serious infection, cardiac complications and neurologic events, along with increased costs of care [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Even minor transfusion such as 1 and 2&#x02009;units of red blood cells is significantly associated with increased morbidity and mortality after OPCAB [<xref ref-type="bibr" rid="CR21">21</xref>]. Reexploration for bleeding is also a common factor in different bleeding classification, which has been reported to be an important source of morbidity after cardiac surgery [<xref ref-type="bibr" rid="CR22">22</xref>]. Therefore, an effective stratifying system for bleeding events according to bleeding-related factors is helpful and necessary to estimate outcomes of cardiac surgery. Although several stratifying systems for severity of perioperative bleeding have been proposed, validation on their prognostic significance was required.</p><p id="Par30">In accordance with our results, the UDPD classification was suggested to have an important effect on both short- and long-term survival after CABG by several studies [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Kinnunen et al. evaluated the clinical significance of UDPB classification in patients undergoing isolated CABG and observed the association between high UDPB classes and poorer immediate and late outcomes [<xref ref-type="bibr" rid="CR23">23</xref>]. In addition to mortality, other adverse outcomes including AKI and low cardiac output were also associated high UDPB classes bleeding. In our recent study, we have confirmed that perioperative bleeding defined as the UDPB class 3 to 4 bleeding was associated with a higher risk of postoperative AKI in ACS patients who underwent OPCAB [<xref ref-type="bibr" rid="CR24">24</xref>]. The UDPB classification was based on the amount of chest tube blood loss, use of blood products and the need of reexploration or delayed sternal closure. Nevertheless, the need of data on transfusion of 6 different blood products makes its application complicated and limited its use in clinical and research activities.</p><p id="Par31">BARC type 4 bleeding is the only one specific CABG-related bleeding definition [<xref ref-type="bibr" rid="CR14">14</xref>]. Bleeding events are much more common in CABG. And transfusion is inherent to cardiopulmonary bypass which makes it difficult to define a threshold for bleeding in CABG [<xref ref-type="bibr" rid="CR25">25</xref>]. Therefore, it is necessary to definite CABG-related, and non&#x02013;CABG-related bleeding separately. BARC type 4 bleeding used the same criteria as the bleeding in the setting of CABG defined by the Thrombolysis in Myocardial Infarction (TIMI) [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR26">26</xref>] bleeding definition which integrated mainly laboratory-based data. It has been confirmed to be associated with 4 to 5 times higher risk of mortality [<xref ref-type="bibr" rid="CR10">10</xref>]. The E-CABG classification measures the severity of bleeding by quantifying the amount of blood products administered to correct anemia and prevent further blood loss as well as reexploration for bleeding. The E-CABG bleeding has been shown robust association with adverse events, such as in-hospital death and prolonged intensive care unit stay, after cardiac surgery [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. On the contrary, the PLATO classification in which drop of hemoglobin played an important role showed poor predictive performance of clinical likely because it was poorly applicable to surgical patients. And BARC classification type 1 to 3 were excluded due to its similarity with PLATO [<xref ref-type="bibr" rid="CR28">28</xref>]. It is noteworthy that decrease in hemoglobin or hematocrit is always included in bleeding definition for nonsurgical operation, such as PLATO bleeding and TIMI non-CABG related bleeding, rather than bleeding definition for surgical operation which emphasize the intervention to reduce ongoing bleeding including blood products transfusion.</p><p id="Par32">The present study provided validation of four different bleeding classification in a large cohort of patients undergoing CABG. We observed that bleeding defined as BARC type 4, E-CABG class 2 and 3 and UDPB class 4 carried a higher risk of in-hospital death and postoperative MI as well as AKI. Such results of our study confirmed that BARC, E-CABG and UDPB were promising research tools for stratification of bleeding risk. Appropriate stratification of bleeding events can provide prognostic information and be useful for estimating the risk of adverse outcomes.</p><p id="Par33">There are some limitations in our study that must be acknowledged. Firstly, the retrospective nature of the present study was an important limitation and prospective data collection might yielded better source documentation to classify bleeding complication. However, the data regarding hemoglobin, transfused blood products and outcomes in hospital were retrieved from medical records system which was considerably reliable. Secondly, the lack of data on follow-up after surgery prevented us to evaluate the long-term effect of major bleeding on the clinical outcomes. But majority of bleeding events and adverse events resulting from bleeding occurred during perioperative period. Thirdly, the present study only enrolled patients undergoing OPCABG and further studies are needed to investigate the prognostic significance of bleeding classifications in patients undergoing other cardiac surgery.</p></sec><sec id="Sec10"><title>Conclusions</title><p id="Par34">Our present study confirmed that bleeding assessed by BARC, E-CABG and UDPB classifications were significantly associated with poorer immediate outcomes but not PLATO classifications. These classifications seemed to be valuable tool in the assessment of prognostic effect of perioperative bleeding events on clinical outcomes. And the significance of these bleeding classifications needs to be validated in a larger population undergoing other cardiac surgery.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AKI</term><def><p id="Par5">Acute kidney injury</p></def></def-item><def-item><term>BARC</term><def><p id="Par6">Bleeding academic research consortium</p></def></def-item><def-item><term>CABG</term><def><p id="Par7">Coronary artery bypass grafting</p></def></def-item><def-item><term>E-CABG</term><def><p id="Par8">European registry of coronary artery bypass grafting</p></def></def-item><def-item><term>MI</term><def><p id="Par9">Myocardial infarction</p></def></def-item><def-item><term>OPCAB</term><def><p id="Par10">Off-pump coronary artery bypass grafting</p></def></def-item><def-item><term>PLATO</term><def><p id="Par11">Platelet inhibition and patient outcomes</p></def></def-item><def-item><term>UDPB</term><def><p id="Par12">Universal definition of perioperative bleeding</p></def></def-item><def-item><term>URL</term><def><p id="Par13">Upper reference limit</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The abstract of the paper was presented at the &#x0201c;ACC.19: The American College of Cardiology 68th Annual Scientific Sessions&#x0201d; [doi: 10.1016/S0735-1097(19)30872-1].</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>WL and ZWX designed the research. ZWX and YNG analyzed and interpreted the data; ZWX performed the statistical analysis and wrote the manuscript. ZXY and YJZ critically revised the manuscript for key intellectual content. All authors approved the final version of the manuscript. WL is responsible for the integrity of the work as a whole.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>There was no funding for this study.</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>The data and other material of this study were available by contacting the corresponding authors.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par35">Ethical approval was obtained from Beijing Anzhen Hospital ethics committee (No. 2018011X). This retrospective study was conducted without informed consent for some objective reasons and was approved by the ethics committee. The protocols of our study obeyed the principles of the 1983 Declaration of Helsinki. The data used in this study was anonymous before its use.</p></notes><notes><title>Consent for publication</title><p id="Par36">Not applicable.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par37">The authors declare that they have no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eikelboom</surname><given-names>JW</given-names></name><name><surname>Mehta</surname><given-names>SR</given-names></name><name><surname>Anand</surname><given-names>SS</given-names></name><name><surname>Xie</surname><given-names>C</given-names></name><name><surname>Fox</surname><given-names>KA</given-names></name><name><surname>Yusuf</surname><given-names>S</given-names></name></person-group><article-title>Adverse impact of bleeding on prognosis in patients with acute coronary syndromes</article-title><source>Circulation</source><year>2006</year><volume>114</volume><issue>8</issue><fpage>774</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.612812</pub-id><pub-id pub-id-type="pmid">16908769</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>SV</given-names></name><name><surname>O'Grady</surname><given-names>K</given-names></name><name><surname>Pieper</surname><given-names>KS</given-names></name><name><surname>Granger</surname><given-names>CB</given-names></name><name><surname>Newby</surname><given-names>LK</given-names></name><name><surname>Van de Werf</surname><given-names>F</given-names></name><name><surname>Mahaffey</surname><given-names>KW</given-names></name><name><surname>Califf</surname><given-names>RM</given-names></name><name><surname>Harrington</surname><given-names>RA</given-names></name></person-group><article-title>Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>9</issue><fpage>1200</fpage><lpage>1206</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2005.06.056</pub-id><pub-id pub-id-type="pmid">16253582</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>KA</given-names></name><name><surname>Acker</surname><given-names>MA</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Bagiella</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>PK</given-names></name><name><surname>Iribarne</surname><given-names>A</given-names></name><name><surname>Kron</surname><given-names>IL</given-names></name><name><surname>Lackner</surname><given-names>P</given-names></name><name><surname>Argenziano</surname><given-names>M</given-names></name><name><surname>Ascheim</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Blood transfusion and infection after cardiac surgery</article-title><source>Ann Thorac Surg</source><year>2013</year><volume>95</volume><issue>6</issue><fpage>2194</fpage><lpage>2201</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2012.11.078</pub-id><pub-id pub-id-type="pmid">23647857</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferraris</surname><given-names>VA</given-names></name><name><surname>Davenport</surname><given-names>DL</given-names></name><name><surname>Saha</surname><given-names>SP</given-names></name><name><surname>Austin</surname><given-names>PC</given-names></name><name><surname>Zwischenberger</surname><given-names>JB</given-names></name></person-group><article-title>Surgical outcomes and transfusion of minimal amounts of blood in the operating room</article-title><source>Arch Surg (Chicago, Ill : 1960)</source><year>2012</year><volume>147</volume><issue>1</issue><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1001/archsurg.2011.790</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>GW</given-names></name><name><surname>Clayton</surname><given-names>TC</given-names></name><name><surname>Mehran</surname><given-names>R</given-names></name><name><surname>Dangas</surname><given-names>G</given-names></name><name><surname>Parise</surname><given-names>H</given-names></name><name><surname>Fahy</surname><given-names>M</given-names></name><name><surname>Pocock</surname><given-names>SJ</given-names></name></person-group><article-title>Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the acute catheterization and urgent intervention triage strategY (ACUITY) trial</article-title><source>Am Heart J</source><year>2012</year><volume>163</volume><issue>3</issue><fpage>522</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2011.11.016</pub-id><pub-id pub-id-type="pmid">22424026</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biancari</surname><given-names>F</given-names></name><name><surname>Tauriainen</surname><given-names>T</given-names></name><name><surname>Perrotti</surname><given-names>A</given-names></name><name><surname>Dalen</surname><given-names>M</given-names></name><name><surname>Faggian</surname><given-names>G</given-names></name><name><surname>Franzese</surname><given-names>I</given-names></name><name><surname>Chocron</surname><given-names>S</given-names></name><name><surname>Ruggieri</surname><given-names>VG</given-names></name><name><surname>Bounader</surname><given-names>K</given-names></name><name><surname>Gulbins</surname><given-names>H</given-names></name><etal/></person-group><article-title>Bleeding, transfusion and the risk of stroke after coronary surgery: A prospective cohort study of 2357 patients</article-title><source>Int J Surg (London, England)</source><year>2016</year><volume>32</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.ijsu.2016.06.032</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brascia</surname><given-names>D</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Onorati</surname><given-names>F</given-names></name><name><surname>Perrotti</surname><given-names>A</given-names></name><name><surname>Ruggieri</surname><given-names>VG</given-names></name><name><surname>Bounader</surname><given-names>K</given-names></name><name><surname>Verhoye</surname><given-names>JP</given-names></name><name><surname>Santarpino</surname><given-names>G</given-names></name><name><surname>Fischlein</surname><given-names>T</given-names></name><name><surname>Maselli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Validation of bleeding classifications in coronary artery bypass grafting</article-title><source>Am J Cardiol</source><year>2017</year><volume>119</volume><issue>5</issue><fpage>727</fpage><lpage>733</lpage><pub-id pub-id-type="doi">10.1016/j.amjcard.2016.11.027</pub-id><pub-id pub-id-type="pmid">28024656</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biancari</surname><given-names>F</given-names></name><name><surname>Ruggieri</surname><given-names>VG</given-names></name><name><surname>Perrotti</surname><given-names>A</given-names></name><name><surname>Svenarud</surname><given-names>P</given-names></name><name><surname>Dalen</surname><given-names>M</given-names></name><name><surname>Onorati</surname><given-names>F</given-names></name><name><surname>Faggian</surname><given-names>G</given-names></name><name><surname>Santarpino</surname><given-names>G</given-names></name><name><surname>Maselli</surname><given-names>D</given-names></name><name><surname>Dominici</surname><given-names>C</given-names></name><etal/></person-group><article-title>European multicenter study on coronary artery bypass grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications</article-title><source>J Cardiothorac Surg</source><year>2015</year><volume>10</volume><fpage>90</fpage><pub-id pub-id-type="doi">10.1186/s13019-015-0292-z</pub-id><pub-id pub-id-type="pmid">26123033</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyke</surname><given-names>C</given-names></name><name><surname>Aronson</surname><given-names>S</given-names></name><name><surname>Dietrich</surname><given-names>W</given-names></name><name><surname>Hofmann</surname><given-names>A</given-names></name><name><surname>Karkouti</surname><given-names>K</given-names></name><name><surname>Levi</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>GJ</given-names></name><name><surname>Sellke</surname><given-names>FW</given-names></name><name><surname>Shore-Lesserson</surname><given-names>L</given-names></name><name><surname>von Heymann</surname><given-names>C</given-names></name><etal/></person-group><article-title>Universal definition of perioperative bleeding in adult cardiac surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>147</volume><issue>5</issue><fpage>1458</fpage><lpage>1463.e1451</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2013.10.070</pub-id><pub-id pub-id-type="pmid">24332097</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikkert</surname><given-names>WJ</given-names></name><name><surname>van Geloven</surname><given-names>N</given-names></name><name><surname>van der Laan</surname><given-names>MH</given-names></name><name><surname>Vis</surname><given-names>MM</given-names></name><name><surname>Baan</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Koch</surname><given-names>KT</given-names></name><name><surname>Peters</surname><given-names>RJ</given-names></name><name><surname>de Winter</surname><given-names>RJ</given-names></name><name><surname>Piek</surname><given-names>JJ</given-names></name><name><surname>Tijssen</surname><given-names>JG</given-names></name><etal/></person-group><article-title>The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis) bleeding classifications</article-title><source>J Am Coll Cardiol</source><year>2014</year><volume>63</volume><issue>18</issue><fpage>1866</fpage><lpage>1875</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2014.01.069</pub-id><pub-id pub-id-type="pmid">24657697</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnunen</surname><given-names>EM</given-names></name><name><surname>Mosorin</surname><given-names>MA</given-names></name><name><surname>Perrotti</surname><given-names>A</given-names></name><name><surname>Ruggieri</surname><given-names>VG</given-names></name><name><surname>Svenarud</surname><given-names>P</given-names></name><name><surname>Dalen</surname><given-names>M</given-names></name><name><surname>Onorati</surname><given-names>F</given-names></name><name><surname>Faggian</surname><given-names>G</given-names></name><name><surname>Santarpino</surname><given-names>G</given-names></name><name><surname>Maselli</surname><given-names>D</given-names></name><etal/></person-group><article-title>Validation of a new classification method of postoperative complications in patients undergoing coronary artery surgery</article-title><source>J Cardiothorac Vasc Anesth</source><year>2016</year><volume>30</volume><issue>2</issue><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1053/j.jvca.2015.09.019</pub-id><pub-id pub-id-type="pmid">26708697</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thygesen</surname><given-names>K</given-names></name><name><surname>Alpert</surname><given-names>JS</given-names></name><name><surname>Jaffe</surname><given-names>AS</given-names></name><name><surname>Chaitman</surname><given-names>BR</given-names></name><name><surname>Bax</surname><given-names>JJ</given-names></name><name><surname>Morrow</surname><given-names>DA</given-names></name><name><surname>White</surname><given-names>HD</given-names></name></person-group><article-title>Fourth universal definition of myocardial infarction (2018)</article-title><source>Eur Heart J</source><year>2019</year><volume>40</volume><issue>3</issue><fpage>237</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy462</pub-id><pub-id pub-id-type="pmid">30165617</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>M</given-names></name><name><surname>Rodrigues</surname><given-names>N</given-names></name><name><surname>Godinho</surname><given-names>I</given-names></name><name><surname>Gameiro</surname><given-names>J</given-names></name><name><surname>Neves</surname><given-names>M</given-names></name><name><surname>Gouveia</surname><given-names>J</given-names></name><name><surname>Costa</surname><given-names>ESZ</given-names></name><name><surname>Lopes</surname><given-names>JA</given-names></name></person-group><article-title>Acute kidney injury in patients with severe sepsis or septic shock: a comparison between the 'Risk, injury, failure, loss of kidney function, end-stage kidney disease' (RIFLE), acute kidney injury network (AKIN) and kidney disease: improving global outcomes (KDIGO) classifications</article-title><source>Clin Kidney J</source><year>2017</year><volume>10</volume><issue>3</issue><fpage>332</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">28616211</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehran</surname><given-names>R</given-names></name><name><surname>Rao</surname><given-names>SV</given-names></name><name><surname>Bhatt</surname><given-names>DL</given-names></name><name><surname>Gibson</surname><given-names>CM</given-names></name><name><surname>Caixeta</surname><given-names>A</given-names></name><name><surname>Eikelboom</surname><given-names>J</given-names></name><name><surname>Kaul</surname><given-names>S</given-names></name><name><surname>Wiviott</surname><given-names>SD</given-names></name><name><surname>Menon</surname><given-names>V</given-names></name><name><surname>Nikolsky</surname><given-names>E</given-names></name><etal/></person-group><article-title>Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium</article-title><source>Circulation</source><year>2011</year><volume>123</volume><issue>23</issue><fpage>2736</fpage><lpage>2747</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.110.009449</pub-id><pub-id pub-id-type="pmid">21670242</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallentin</surname><given-names>L</given-names></name><name><surname>Becker</surname><given-names>RC</given-names></name><name><surname>Budaj</surname><given-names>A</given-names></name><name><surname>Cannon</surname><given-names>CP</given-names></name><name><surname>Emanuelsson</surname><given-names>H</given-names></name><name><surname>Held</surname><given-names>C</given-names></name><name><surname>Horrow</surname><given-names>J</given-names></name><name><surname>Husted</surname><given-names>S</given-names></name><name><surname>James</surname><given-names>S</given-names></name><name><surname>Katus</surname><given-names>H</given-names></name><etal/></person-group><article-title>Ticagrelor versus clopidogrel in patients with acute coronary syndromes</article-title><source>N Engl J Med</source><year>2009</year><volume>361</volume><issue>11</issue><fpage>1045</fpage><lpage>1057</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa0904327</pub-id><pub-id pub-id-type="pmid">19717846</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajjar</surname><given-names>LA</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Galas</surname><given-names>FR</given-names></name><name><surname>Nakamura</surname><given-names>RE</given-names></name><name><surname>Silva</surname><given-names>CM</given-names></name><name><surname>Santos</surname><given-names>MH</given-names></name><name><surname>Fukushima</surname><given-names>J</given-names></name><name><surname>Kalil Filho</surname><given-names>R</given-names></name><name><surname>Sierra</surname><given-names>DB</given-names></name><name><surname>Lopes</surname><given-names>NH</given-names></name><etal/></person-group><article-title>Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial</article-title><source>Jama</source><year>2010</year><volume>304</volume><issue>14</issue><fpage>1559</fpage><lpage>1567</lpage><pub-id pub-id-type="doi">10.1001/jama.2010.1446</pub-id><pub-id pub-id-type="pmid">20940381</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohnle</surname><given-names>P</given-names></name><name><surname>Snyder-Ramos</surname><given-names>SA</given-names></name><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Kulier</surname><given-names>A</given-names></name><name><surname>Bottiger</surname><given-names>BW</given-names></name><name><surname>Levin</surname><given-names>J</given-names></name><name><surname>Mangano</surname><given-names>DT</given-names></name></person-group><article-title>Postoperative red blood cell transfusion and morbid outcome in uncomplicated cardiac surgery patients</article-title><source>Intensive Care Med</source><year>2011</year><volume>37</volume><issue>1</issue><fpage>97</fpage><lpage>109</lpage><pub-id pub-id-type="doi">10.1007/s00134-010-2017-z</pub-id><pub-id pub-id-type="pmid">20721533</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loor</surname><given-names>G</given-names></name><name><surname>Rajeswaran</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sabik</surname><given-names>JF</given-names><suffix>3rd</suffix></name><name><surname>Blackstone</surname><given-names>EH</given-names></name><name><surname>McCrae</surname><given-names>KR</given-names></name><name><surname>Koch</surname><given-names>CG</given-names></name></person-group><article-title>The least of 3 evils: exposure to red blood cell transfusion, anemia, or both?</article-title><source>J Thorac Cardiovasc Surg</source><year>2013</year><volume>146</volume><issue>6</issue><fpage>1480</fpage><lpage>1487.e1486</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2013.06.033</pub-id><pub-id pub-id-type="pmid">23998782</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>CG</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Duncan</surname><given-names>AI</given-names></name><name><surname>Mihaljevic</surname><given-names>T</given-names></name><name><surname>Cosgrove</surname><given-names>DM</given-names></name><name><surname>Loop</surname><given-names>FD</given-names></name><name><surname>Starr</surname><given-names>NJ</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting</article-title><source>Crit Care Med</source><year>2006</year><volume>34</volume><issue>6</issue><fpage>1608</fpage><lpage>1616</lpage><pub-id pub-id-type="doi">10.1097/01.CCM.0000217920.48559.D8</pub-id><pub-id pub-id-type="pmid">16607235</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>GJ</given-names></name><name><surname>Reeves</surname><given-names>BC</given-names></name><name><surname>Rogers</surname><given-names>CA</given-names></name><name><surname>Rizvi</surname><given-names>SI</given-names></name><name><surname>Culliford</surname><given-names>L</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name></person-group><article-title>Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery</article-title><source>Circulation</source><year>2007</year><volume>116</volume><issue>22</issue><fpage>2544</fpage><lpage>2552</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.698977</pub-id><pub-id pub-id-type="pmid">17998460</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paone</surname><given-names>G</given-names></name><name><surname>Likosky</surname><given-names>DS</given-names></name><name><surname>Brewer</surname><given-names>R</given-names></name><name><surname>Theurer</surname><given-names>PF</given-names></name><name><surname>Bell</surname><given-names>GF</given-names></name><name><surname>Cogan</surname><given-names>CM</given-names></name><name><surname>Prager</surname><given-names>RL</given-names></name></person-group><article-title>Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality</article-title><source>Ann Thorac Surg</source><year>2014</year><volume>97</volume><issue>1</issue><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2013.07.020</pub-id><pub-id pub-id-type="pmid">24094521</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karthik</surname><given-names>S</given-names></name><name><surname>Grayson</surname><given-names>AD</given-names></name><name><surname>McCarron</surname><given-names>EE</given-names></name><name><surname>Pullan</surname><given-names>DM</given-names></name><name><surname>Desmond</surname><given-names>MJ</given-names></name></person-group><article-title>Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay</article-title><source>Ann Thorac Surg</source><year>2004</year><volume>78</volume><issue>2</issue><fpage>527</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2004.02.088</pub-id><pub-id pub-id-type="pmid">15276512</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnunen</surname><given-names>EM</given-names></name><name><surname>Juvonen</surname><given-names>T</given-names></name><name><surname>Airaksinen</surname><given-names>KE</given-names></name><name><surname>Heikkinen</surname><given-names>J</given-names></name><name><surname>Kettunen</surname><given-names>U</given-names></name><name><surname>Mariscalco</surname><given-names>G</given-names></name><name><surname>Biancari</surname><given-names>F</given-names></name></person-group><article-title>Clinical significance and determinants of the universal definition of perioperative bleeding classification in patients undergoing coronary artery bypass surgery</article-title><source>J Thorac Cardiovasc Surg</source><year>2014</year><volume>148</volume><issue>4</issue><fpage>1640</fpage><lpage>1646.e1642</lpage><pub-id pub-id-type="doi">10.1016/j.jtcvs.2014.07.040</pub-id><pub-id pub-id-type="pmid">25260277</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Xi</surname><given-names>Z</given-names></name><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Dong</surname><given-names>R</given-names></name><name><surname>AlHelal</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name></person-group><article-title>Impact of major bleeding on the risk of acute kidney injury in patients undergoing off-pump coronary artery bypass grafting</article-title><source>J Thorac Dis</source><year>2018</year><volume>10</volume><issue>6</issue><fpage>3381</fpage><lpage>3389</lpage><pub-id pub-id-type="doi">10.21037/jtd.2018.05.98</pub-id><pub-id pub-id-type="pmid">30069333</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinnunen</surname><given-names>EM</given-names></name><name><surname>De Feo</surname><given-names>M</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Tauriainen</surname><given-names>T</given-names></name><name><surname>Gatti</surname><given-names>G</given-names></name><name><surname>Onorati</surname><given-names>F</given-names></name><name><surname>Maschietto</surname><given-names>L</given-names></name><name><surname>Bancone</surname><given-names>C</given-names></name><name><surname>Fiorentino</surname><given-names>F</given-names></name><name><surname>Chocron</surname><given-names>S</given-names></name><etal/></person-group><article-title>Incidence and prognostic impact of bleeding and transfusion after coronary surgery in low-risk patients</article-title><source>Transfusion</source><year>2017</year><volume>57</volume><issue>1</issue><fpage>178</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1111/trf.13885</pub-id><pub-id pub-id-type="pmid">27774615</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rao</surname><given-names>AK</given-names></name><name><surname>Pratt</surname><given-names>C</given-names></name><name><surname>Berke</surname><given-names>A</given-names></name><name><surname>Jaffe</surname><given-names>A</given-names></name><name><surname>Ockene</surname><given-names>I</given-names></name><name><surname>Schreiber</surname><given-names>TL</given-names></name><name><surname>Bell</surname><given-names>WR</given-names></name><name><surname>Knatterud</surname><given-names>G</given-names></name><name><surname>Robertson</surname><given-names>TL</given-names></name><name><surname>Terrin</surname><given-names>ML</given-names></name></person-group><article-title>Thrombolysis in myocardial infarction (TIMI) trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase</article-title><source>J Am Coll Cardiol</source><year>1988</year><volume>11</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/0735-1097(88)90158-1</pub-id><pub-id pub-id-type="pmid">3121710</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariscalco</surname><given-names>G</given-names></name><name><surname>Gherli</surname><given-names>R</given-names></name><name><surname>Ahmed</surname><given-names>AB</given-names></name><name><surname>Zanobini</surname><given-names>M</given-names></name><name><surname>Maselli</surname><given-names>D</given-names></name><name><surname>Dalen</surname><given-names>M</given-names></name><name><surname>Piffaretti</surname><given-names>G</given-names></name><name><surname>Cappabianca</surname><given-names>G</given-names></name><name><surname>Beghi</surname><given-names>C</given-names></name><name><surname>Biancari</surname><given-names>F</given-names></name></person-group><article-title>Validation of the European multicenter study on coronary artery bypass grafting (E-CABG) bleeding severity definition</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>5</issue><fpage>1782</fpage><lpage>1788</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2015.10.028</pub-id><pub-id pub-id-type="pmid">26707003</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>RC</given-names></name><name><surname>Bassand</surname><given-names>JP</given-names></name><name><surname>Budaj</surname><given-names>A</given-names></name><name><surname>Wojdyla</surname><given-names>DM</given-names></name><name><surname>James</surname><given-names>SK</given-names></name><name><surname>Cornel</surname><given-names>JH</given-names></name><name><surname>French</surname><given-names>J</given-names></name><name><surname>Held</surname><given-names>C</given-names></name><name><surname>Horrow</surname><given-names>J</given-names></name><name><surname>Husted</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient outcomes (PLATO) trial</article-title><source>Eur Heart J</source><year>2011</year><volume>32</volume><issue>23</issue><fpage>2933</fpage><lpage>2944</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehr422</pub-id><pub-id pub-id-type="pmid">22090660</pub-id></element-citation></ref></ref-list></back></article>